- Home
- KYMR vs MIR Comparison
KYMR vs MIR Comparison
Compare KYMR & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | MIR |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.7B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KYMR | MIR |
|---|---|---|
| Price | $71.78 | $26.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 24 | 7 |
| Target Price | ★ $105.35 | $28.29 |
| AVG Volume (30 Days) | 694.8K | ★ 2.0M |
| Earning Date | 02-26-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $43,735,000.00 | ★ $902,300,000.00 |
| Revenue This Year | $18.70 | $8.75 |
| Revenue Next Year | N/A | $23.17 |
| P/E Ratio | ★ N/A | $263.83 |
| Revenue Growth | N/A | ★ 7.82 |
| 52 Week Low | $19.45 | $12.00 |
| 52 Week High | $103.00 | $30.28 |
Technical Indicators
Market Signals| Indicator | KYMR | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 45.83 | 59.95 |
| Support Level | $66.21 | $25.73 |
| Resistance Level | $76.71 | $27.40 |
| Average True Range (ATR) | 3.80 | 1.04 |
| MACD | -0.84 | 0.24 |
| Stochastic Oscillator | 50.30 | 85.61 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.